Evidence map›Paper›PMID 35344225›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

Prph2 disease mutations lead to structural and functional defects in the RPE.

Lars Tebbe, Haarthi Sakthivel, Mustafa S Makia, Mashal Kakakhel, Shannon M Conley, Muayyad R Al-Ubaidi, Muna I Naash

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lars TebbeDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.ORCID 0000-0003-3081-6580
Haarthi SakthivelDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Mustafa S MakiaDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Mashal KakakhelDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Shannon M ConleyDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-7550-3898
Muayyad R Al-UbaidiDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.ORCID 0000-0002-4914-350X
Muna I NaashDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.ORCID 0000-0002-6534-5144
University of Houston · USUniversity of Oklahoma Health Sciences Center · US

Funding

Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Veronica Galvan, William Edmund Sonntag · 2019 to 2026
$17.8M
Supplement for: Mechanism of Photoreceptor Cell Degeneration in Animal Models of Retinal DiseasesR01EY010609 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI MUAYYAD R AL-UBAIDI, Muna I. Naash · 1995 to 2026
$11.0M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Compacted DNA Nanoparticles for Ocular TherapyR01EY018656 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AL-UBAIDI, MUAYYAD R, NAASH, MUNA I. · 2008 to 2021
$5.6M
The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementiaR01AG070915 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CONLEY, SHANNON M · 2021 to 2025
$1.8M
Mechanism of photoreceptor cell degeneration in animal models of retinal diseasesR56EY010609 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI NAASH, MUNA I. · 2008 to 2008
$479k
NEI NIH HHS R01 EY010609NEI NIH HHS R01 EY018656NEI NIH HHS R56 EY010609NIA NIH HHS R01 AG070915NIGMS NIH HHS P20 GM125528
6 · The paper itself

Abstract

Prph2 is a photoreceptor-specific tetraspanin with an essential role in the structure and function of photoreceptor outer segments. PRPH2 mutations cause a multitude of retinal diseases characterized by the degeneration of photoreceptors as well as defects in neighboring tissues such as the RPE. While extensive research has analyzed photoreceptors, less attention has been paid to these secondary defects. Here, we use different Prph2 disease models to evaluate the damage of the RPE arising from photoreceptor defects. In Prph2 disease models, the RPE exhibits structural abnormalities and cell loss. Furthermore, RPE functional defects are observed, including impaired clearance of phagocytosed outer segment material and increased microglia activation. The severity of RPE damage is different between models, suggesting that the different abnormal outer segment structures caused by Prph2 disease mutations lead to varying degrees of RPE stress and thus influence the clinical phenotype observed in patients.

Indexed as

PeripherinsRetinal DiseasesTetraspaninsHumansMutationPhotoreceptor CellsRetinal Pigment EpitheliumPeripherinsPRPH2 protein, humanTetraspaninsAB_10003146AB_2285290AB_2533073AB_2535792AB_2535794AB_2536180AB_2833006AB_571111AB_628459AB_785511AB_839504macular degenerationphagocytosisPrph2RPE

Identifiers

PMID35344225
PMCPMC10599796
OpenAlexW4220744428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.